Gel Documentation Systems Market Research Report - Global Forecast till 2027

Gel Documentation Systems Market Research Report: by Product (Instruments, Accessories, Software’s), by Detection Technique (Ultraviolet, Fluorescence, Chemiluminescence), By Application (Protein Quantification, Others), By End User - Global Forecast Till 2027

ID: MRFR/MED/5443-HCR | February 2021 | Region: Global | 90 pages

Gel Documentation Systems Market Scenario:


Gel Documentation Systems Market is expected to grow significantly over the forecast period. The market held a market value of USD 245 Million in 2017 and is projected to grow at a CAGR of 3.6% over the forecast period. Gel documentation system or gel imaging systems are mainly used to record, and measure labelled nucleic acid and protein in several types of media such as agarose, acrylamide or cellulose. These systems have applications in protein quantification, monoclonal and polyclonal antibody binding affinities, gel and blot imaging, immunoassay, 2D electrophoresis, and nucleic acid quantification among others.


The factors such as increasing prevalence of infectious diseases and genetic disorders, growing government funding’s for genomic and proteomic research, and the on-going technological advancements in gel documentation systems is anticipated to boost the growth of the market over the forecast period. According to the Centers for Disease Control and Prevention (CDC), about 9,272 number of new tuberculosis cases were reported in 2016 in the US. Despite the drivers, the high cost of modern gel documentation systems with advanced technologies and the increasing adoption of quantitative polymerase chain reaction (QPCR) may hinder the Gel Documentation Systems Market growth during the assessment period.


Gel Documentation Systems Market Segmentation:


The Market has been segmented into Product, Detection techniques, Application and End user.


By product, the market has been segmented into instruments, accessories, and software. The instrument segment has been further segmented into digital gel documentation instruments and film gel documentation instruments. The instruments segment is estimated to hold major market share in the global gel documentation systems market due to the rising R&D activities in the biotechnology and pharmaceutical industries.On the basis of detection technique, the market has been segmented into ultraviolet, chemiluminescence, and fluorescence.On the basis of application, the market has been segmented into protein quantification, nucleic acid quantification, and others.


The market, by end user, has been segmented into pharmaceutical & biotechnology companies, academic institutes & research centers, diagnostic laboratories, and others.The Global Market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The gel documentation systems market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European Gel Documentation Systems Market has been segmented into Western Europe and Eastern Europe. The Western Europe Market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Gel Documentation Systems Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players:


Bio-Rad Laboratories, Inc., Bio-Techne, Endress + Hauser Management AG, GE Healthcare, Thermo Fisher Scientific, LI-COR Biosciences, Vilber Lourmat, Scientific Digital Imaging Plc., Cleaver Scientific, and Azure Biosystems are some of the prominent players in the global gel documentation systems market.


Regional Market Summary


Global Gel Documentation Systems Share (%), by Region, 2017


Source: White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the Gel Documentation Systems industry owing to the high clinical R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies, and rising adoption of advanced technologies. According to the US Investments in Medical and Health Research and Development 2013-2015, a report by Research America, in 2015, total US medical and health R&D in the US was USD 158.7 billion. Moreover, the increasing prevalence of genetic disorders in the region contributes to the market growth.


Europe is expected to hold the second largest position in the Gel Documentation Systems Market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).


The Gel Documentation Systems Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of proteomic and genomic studies in the region.


The Middle East & Africa has the lowest share of the  Gel Documentation Systems Market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.


Global Market, by Product:



  • Instruments



  •    Digital Gel Documentation Instruments

  •    Film Gel Documentation Instruments



  • Software

  • Accessories


Market for Gel Documentation Systems , by Detection Technique:



  •      Ultraviolet

  •      Chemiluminescence

  •      Fluorescence


Market for Gel Documentation Systems, by Application:



  •       Protein Quantification

  •       Nucleic Acid Quantification

  •       Others


Market for Gel Documentation Systems, by End User:



  •      Pharmaceutical & Biotechnology Companies

  •      Academic Institutes & Research Centers

  •      Diagnostic Laboratories

  •      Others


Market for Gel Documentation Systems, by Region:



  • Americas



  •    North America

  •    US

  •    Canada

  •    South America



  • Europe



  •    Western Europe

  •    Germany

  •    France

  •    Italy

  •    Spain

  •    UK

  •    Rest of Western Europe

  •    Eastern Europe



  • Asia-Pacific



  •    Japan

  •    China

  •    India

  •    Australia

  •    South Korea

  •    Rest of Asia-Pacific



  • The Middle East & Africa



  •    Middle East

  •    Africa


Market for Gel Documentation Systems, by Key Players:



  •      Bio-Rad Laboratories, Inc.

  •      Bio-Techne

  •      Endress + Hauser Management AG

  •      GE Healthcare

  •      Thermo Fisher Scientific

  •       LI-COR Biosciences

  •       Vilber Lourmat

  •       Scientific Digital Imaging Plc.

  •       Cleaver Scientific

  •       Azure Biosystems

  •       Others


Intended Audience:



  • Gel Documentation System Manufacturers and Distributors

  • Pharmaceutical and Biotechnological Companies

  • Contract Research Organizations

  • Academic and Research Institutes

  • Government Associations



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 245 Million
  CAGR   3.6% (2018 - 2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Product, Detection Technique, Application, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Bio-Rad Laboratories, Inc., Bio-Techne, Endress + Hauser Management AG, GE Healthcare, Thermo Fisher Scientific, LI-COR Biosciences, Vilber Lourmat, Scientific Digital Imaging Plc., Cleaver Scientific, and Azure Biosystems
  Key Market Opportunities   Increasing research & development investments by industry players
  Key Market Drivers

  • Increasing prevalence of infectious diseases and genetic disorders
  • On-going technological advancements


  • Speak to Analyst Ask for Customization